Brussels is negotiating a new Covid-19 vaccine procurement deal with US drugmaker Moderna as EU health authorities grow concerned about a rise in coronavirus infections.
The deal is being negotiated between Brussels and the biotechnology group, two people familiar with the matter said, with member states able to confirm their interest on an individual basis.
At least eight EU countries were interested in opting into a new supply deal, one of the people said, adding that the contract was specifically for messenger ribonucleic acid-based Covid-19 vaccines. BioNTech/Pfizer, the other manufacturer of mRNA jabs, already has a multiyear deal with the EU.
您已閱讀26%（656字），剩余74%（1847字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。